Literature DB >> 5683825

Smallpox vaccination of eczema patients with attenuated live vaccinia virus.

C H Kempe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5683825      PMCID: PMC2591438     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


× No keyword cloud information.
  9 in total

1.  ILLNESSES ATTRIBUTED TO SMALLPOX VACCINATION, 1951-60. II. ILLNESSES REPORTED AS AFFECTING THE CENTRAL NERVOUS SYSTEM.

Authors:  E T CONYBEARE
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1964-09

2.  PROPHYLACTIC TREATMENT OF SMALL POX CONTACTS WITH N-METHYLISATIN BETA-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN).

Authors:  D J BAUER; L STVINCENT; C H KEMPE; A W DOWNIE
Journal:  Lancet       Date:  1963-09-07       Impact factor: 79.321

3.  Studies smallpox and complications of smallpox vaccination.

Authors:  C H KEMPE
Journal:  Pediatrics       Date:  1960-08       Impact factor: 7.124

4.  Complications of smallpox vaccination. I. National survey in the United States, 1963.

Authors:  J M Neff; J M Lane; J H Pert; R Moore; J D Millar; D A Henderson
Journal:  N Engl J Med       Date:  1967-01-19       Impact factor: 91.245

5.  Smallpox immunization in the United States.

Authors:  C H Kempe; A S Benenson
Journal:  JAMA       Date:  1965-10-11       Impact factor: 56.272

6.  AMOUNT AND DURATION OF IMMUNITY INDUCED BY INTRADERMAL INOCULATION OF CULTURED VACCINE VIRUS.

Authors:  T M Rivers; S M Ward; R D Baird
Journal:  J Exp Med       Date:  1939-05-31       Impact factor: 14.307

7.  FURTHER STUDIES OF THE INFECTIOUS UNIT OF VACCINIA.

Authors:  R F Parker; L H Bronson; R H Green
Journal:  J Exp Med       Date:  1941-08-31       Impact factor: 14.307

8.  CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MAN.

Authors:  T M Rivers
Journal:  J Exp Med       Date:  1931-09-30       Impact factor: 14.307

9.  JENNERIAN PROPHYLAXIS BY MEANS OF INTRADERMAL INJECTIONS OF CULTURE VACCINE VIRUS.

Authors:  T M Rivers; S M Ward
Journal:  J Exp Med       Date:  1935-09-30       Impact factor: 14.307

  9 in total
  5 in total

1.  A possible relation between human pathogenicity of smallpox vaccines and virus growth at elevated temperatures.

Authors:  D Baxby
Journal:  J Hyg (Lond)       Date:  1974-08

2.  Effect of heat-labile factors on the neutralization of vaccinia virus by human.

Authors:  K Takabayashi; K McIntosh
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

Review 3.  Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.

Authors:  Stephen R Walsh; Raphael Dolin
Journal:  Expert Rev Vaccines       Date:  2011-08       Impact factor: 5.217

4.  Why is eczema herpeticum unexpectedly rare?

Authors:  Donald Y M Leung
Journal:  Antiviral Res       Date:  2013-02-22       Impact factor: 5.970

Review 5.  LC16m8: an attenuated smallpox vaccine.

Authors:  Julie Kenner; Fiona Cameron; Cyril Empig; David V Jobes; Marc Gurwith
Journal:  Vaccine       Date:  2006-04-21       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.